Financing - April 29, 2024
Immunovia moves lab and US headquarters to Research Triangle Park, North Carolina
Moving its lab and U.S. headquarters to Research Triangle Park supports the strategy Immunovia announced in July 2023 to streamline operations and reduce costs. The move to Research Triangle Park follows Immunovia’s model development study and completion of the discovery phase for its next-generation test in November 2023. Following these developments, the company will focus […]
Biotech Business - April 29, 2024
XNK Therapeutics has been declared into bankruptcy
About half of the 26 employees were made redundant prior to the bankruptcy and the other half have had their employment agreements terminated following the bankruptcy. As things stand, most of the members of the leadership team are available for a short period of time to ensure compliance with applicable regulatory requirements and to assist […]
Financing - April 29, 2024
AI Medical Technology raises USD 1 million
The company has announced the successful closure of an oversubscribed bridge financing round. Funding was provided by existing investors, such as Northern Venture CapSek, and new shareholders. The money will be used to support ongoing regulatory efforts and development of the company’s AI-driven support tool, Dermalyser, a clinically validated decision support tool for the diagnosis […]
Biotech Business - April 17, 2024
Sound Bioventures announces investment in Theolytics
Sound Bioventures participated in the financing round, which raised a total of USD 24.5 million, and joins an existing investor syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and the University of Oxford. In conjunction with this financing, Thomas Tan, Principal at Sound Bioventures, will join Theolytics’ Board of Directors. Read more: […]
CDMO - April 15, 2024
Curida secures equity investment and appoints new CEO
Curida Holding has announced a significant growth investment from Signet Healthcare Partners, a New York-based healthcare private equity firm together with existing shareholders, Canica, Investinor, Klaveness Marine and Farvatn Private Equity. This investment will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry position, it states. The total investment […]
Business article - April 12, 2024
InDex Pharmaceuticals provides a company update
InDex Pharmaceuticals has announced that the evaluation of alternatives for the company’s future has been finalized and presented to the Board according to plan. A step-wise approach was adopted to narrow down the number of options. The evaluation was conducted with support from an external financial advisor with the aim to maximize shareholder value. The […]
